Alquil-lysophospholipids and cancer: development of lipid nanoparticles for oral administration and preclinical studies
Current leukemia treatments are generally associated to severe side-effects and relapse is frequent in adults. Edelfosine (ET) is the prototype of a family of antitumor drugs with potent antitumor effects against several cancer types. However, the use of ET in clinic remains limited due to ET side-e...
| Hauptverfasser: | , |
|---|---|
| Format: | info:eu-repo/semantics/doctoralThesis |
| Sprache: | eng |
| Veröffentlicht: |
2016
|
| Schlagworte: | |
| Online Zugang: | https://hdl.handle.net/10171/40089 |